EP-104GI

· Eupraxia Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EP-104GI, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). [Phase 1, Phase 2]